The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome

Table 4 Clinical characteristics of the participants of the CoLaus study, by gender.

	Overall (n = 6,188)	Women (n = 3,251)	Men (n = 2,937)	P value
ASAT (U/L)	29.96 ± 14.04	26.22 ± 9.88	34.10 ± 16.57	<0.001
ALAT (U/L)	27.84 ± 19.50	21.98 ± 14.47	34.32 ± 22.13	<0.001
Alkaline phosphatase (U/L)	63.47 ± 20.72	62.66 ± 20.99	64.38 ± 20.38	<0.001
Gamma-GT (U/L)	33.20 ± 59.04	22.95 ± 25.78	44.57 ± 79.80	<0.001
Calcium (mmol/L)	2.29 ± 0.09	2.28 ± 0.10	2.29 ± 0.09	<0.001
Albumin (g/L)	44.20 ± 2.53	43.73 ± 2.48	44.71 ± 2.48	<0.001
Total protein (g/L)	74.41 ± 4.39	73.93 ± 4.42	74.95 ± 4.30	<0.001
Uric acid (μmol/L)	313.49 ± 84.47	270.56 ± 67.23	361.08 ± 75.69	<0.001
CDT (% of total transferrin)	0.95 ± 0.81	0.80 ± 0.48	1.12 ± 1.02	<0.001

Results are expressed as mean ± SD. ASAT: Aspartate amino-transferase. ALAT: Alanine amino-transferase. Gamma-GT: Gamma-glutaryl-transferase. CDT: Carbohydrate deficient transferrin. Statistical analysis between genders by Student's t-test or chi-square test.

ISSN: 1471-2261